Photolitec Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $961K

  • Investors
  • 5

Photolitec General Information

Description

Developer of photosensitizing compounds designed to identify cancer through medical imaging. The company's photosensitizing compounds are designed to overcome limitations associated with the agents currently on the market, enabling healthcare providers to identify deeply-seated tumors of patients and provide treatment to cure cancer.

Contact Information

Website
www.photolitec.org
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 73 High Street
  • Suite 207
  • Buffalo, NY 14203
  • United States
+1 (716)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 73 High Street
  • Suite 207
  • Buffalo, NY 14203
  • United States
+1 (716)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Photolitec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Grant 07-Sep-2020 $961K Completed Generating Revenue
8. Grant 12-Sep-2017 Completed Generating Revenue
7. Grant 01-Jan-2017 Completed Generating Revenue
6. Later Stage VC 07-Jan-2016 Completed Generating Revenue
5. Later Stage VC 03-Mar-2015 Completed Startup
4. Grant 01-Jan-2014 Completed Startup
3. Grant 01-Jan-2013 Completed Startup
2. Angel (individual) 11-Feb-2011 $630K $630K Completed Startup
1. Accelerator/Incubator 01-Jan-2011 Completed Generating Revenue
To view Photolitec’s complete valuation and funding history, request access »

Photolitec Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of photosensitizing compounds designed to identify cancer through medical imaging. The company's photosensitiz
Diagnostic Equipment
Buffalo, NY
11 As of 2015

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Photolitec Competitors (1)

One of Photolitec’s competitors is Agios Pharmaceuticals, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agios Pharmaceuticals Formerly VC-backed Cambridge, MA
You’re viewing 1 of 1 competitors. Get the full list »

Photolitec Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Photolitec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210236840-A1 Combined sonodynamic and photodynamic therapy to treat deep seated cancer and other hyperpoliferative disease and ultrasound and light triggered release of near infrared photosensitizers and chemotherapy agents from polyacrlamide based nanoparticles Inactive 30-Jan-2020
US-11083793-B2 Epidermal growth factor receptor (egfr) targeted photosensitizers Active 13-Dec-2016
US-20200078461-A1 Epidermal growth factor receptor (egfr) targeted photosensitizers Active 13-Dec-2016
EP-3554549-A1 Epidermal growth factor receptor (egfr) targeted photosensitizers Pending 13-Dec-2016
EP-3554549-A4 Epidermal growth factor receptor (egfr) targeted photosensitizers Pending 13-Dec-2016 A61K41/0076
To view Photolitec’s complete patent history, request access »

Photolitec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Photolitec Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Zhejiang Hisun Pharmaceutical Company Corporation Minority
Ami Organics Corporation Minority
National Cancer Institute Government
Innovation Partnerships Venture Capital Minority
To view Photolitec’s complete investors history, request access »

Photolitec Investments (1)

Photolitec’s most recent deal was a Joint Venture with Ami Onco-Theranostics. The deal was made on 01-Jan-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ami Onco-Theranostics 01-Jan-2015 Joint Venture Biotechnology
To view Photolitec’s complete investments history, request access »

Ready to get started?

Request a free trial

Photolitec FAQs

  • When was Photolitec founded?

    Photolitec was founded in 2007.

  • Where is Photolitec headquartered?

    Photolitec is headquartered in Buffalo, NY.

  • What is the size of Photolitec?

    Photolitec has 11 total employees.

  • What industry is Photolitec in?

    Photolitec’s primary industry is Diagnostic Equipment.

  • Is Photolitec a private or public company?

    Photolitec is a Private company.

  • What is Photolitec’s current revenue?

    The current revenue for Photolitec is .

  • How much funding has Photolitec raised over time?

    Photolitec has raised $8.63M.

  • Who are Photolitec’s investors?

    National Institutes of Health, Zhejiang Hisun Pharmaceutical Company, Ami Organics, National Cancer Institute, and Innovation Partnerships have invested in Photolitec.

  • Who are Photolitec’s competitors?

    Agios Pharmaceuticals is a competitor of Photolitec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »